![]() |
Low HDL Cholesterol |
Credits: 1.00 Post-Assessment Questions: 5
Release Date: 5 Oct 2020
Expiration Date: 14 Dec 2021
Last Reviewed: 14 Dec 2020
Estimated Time To Finish: 60 Minutes
Need Help? If you have a system or content concerns, please contact support@statpearls.com, or call (727) 289-9796.
HDL cholesterol levels have been believed to be cardioprotective for many years. Recent studies examining pharmacologic elevation of HDL through various methods have not demonstrated a reduction in coronary vascular disease progression. This resulted in further study of the relationship of HDL particle number with HDL level as well as the many functions of HDL and the role they play in antiatherogenic properties. This has been identified as a potential secondary target for those with cardiovascular disease who have reached maximum LDL lowering benefit on lipid-lowering medications. We will also look at the various hereditary disorders and genetic mutations that result in low HDL states and the various effects these have on cardiovascular risk. This activity will examine the drugs that affect HDL cholesterol level, particle number, and function while also examining the clinical benefit. Lastly, it will highlight the importance of the interprofessional team in supporting the nutrition and exercise changes that improve HDL levels as well as cardiovascular health.
This activity has been designed to meet the educational needs of physicians.
At the conclusion of this activity, the learner will be better able to:
Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.
COMMERCIAL SUPPORT: This activity has received NO commercial support.
Hover over the contributor names to see details and disclosures of any financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.
Authors: Susan Hageman
Editors: Saurabh Sharma
Editors-In-Chief: Wantzy CooperBabak AbaiChiranjiv Virk
Chief Medical Reviewer: Muhammad Hashmi
Nurse Planner/Reviewer/Editor: Lisa Haddad
Nurse Planner/Reviewer/Editor: Bernadette Makar
Nurse Planner/Reviewer/Editor: Dorothy Caputo
Pharmacy Planner/Reviewer/Editor: Mark Pellegrini
Physician Planner/Reviewer/Editor: Scott Dulebohn
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.
Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.
Equal Opportunity
Medium or Media Used:
Instructions for Credit
StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity. All copyrights are reserved.
5 Star | |
4 Star | |
3 Star | |
2 Star | |
1 Star |
Stay up to date on the latest medical knowledge with 6004 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 6547.75 hours of CME.